Triple
T22041526
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Medicare Prescription Drug, Improvement, and Modernization Act of 2003 |
E544646
|
entity |
| Predicate | alsoKnownAs |
P39
|
FINISHED |
| Object | Medicare Prescription Drug Benefit law |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medicare Prescription Drug Benefit law | Statement: [Medicare Prescription Drug, Improvement, and Modernization Act of 2003, alsoKnownAs, Medicare Prescription Drug Benefit law]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Medicare Prescription Drug Benefit law Context triple: [Medicare Prescription Drug, Improvement, and Modernization Act of 2003, alsoKnownAs, Medicare Prescription Drug Benefit law]
-
A.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
chosen
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
-
B.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
C.
Prescription Drug Marketing Act
The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
-
D.
Medicaid Drug Rebate Program
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
-
E.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e32445c8190ab97089b48a130bb |
completed | April 16, 2026, 5:36 p.m. |
| NER | Named-entity recognition | batch_69f12829c1c081909edc7544242c9c7a |
completed | April 28, 2026, 9:35 p.m. |
Created at: April 16, 2026, 8:25 p.m.